OSR Holdings Inc (NASDAQ: OSRH) — Healthcare · Share Price, Chart & Market Data
About: OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.69 (+16.43%)
OSRHOSR Holdings Inc
Loading watchlist status…
Trade OSRH now
OSR Holdings Inc share price
OSRH price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 11:05 am GMT+0
OSRH price performance
17.478%
5D
49.128%
1M
17.577%
YTD
-49.964%
1Y
OSRH price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 11:05 am GMT+0
OSRH details
OSRH Market Signals